Expert Review of Pharmacoeconomics and Outcomes Research

What's the trade-off between comparative effectiveness and cost-effectiveness analysis?
pp. 425-426(2)
Author: Zhang, James X

News in brief
pp. 427-431(5)

Is trastuzumab a cost-effective treatment for breast cancer?
pp. 433-442(10)
Authors: Younis, Tallal; Skedgel, Chris

Addressing the needs of cancer survivors: issues and challenges
pp. 443-451(9)
Author: Corner, Jessica

Converting condition-specific measures into preference-based outcomes for use in economic evaluation
pp. 453-461(9)
Authors: Petrillo, Jennifer; Cairns, John

Impact of patient sample on costs of events in pharmacoeconomic models
pp. 463-469(7)
Authors: Mullins, C Daniel; Subedi, Prasun R; Turk, Florian

Estimating health effects in quality-of-life terms: health losses following road crashes
pp. 471-477(7)
Authors: Cubí-Mollá, Patricia

Influence of response shift on evaluations of change in patient-reported outcomes
pp. 479-489(11)
Authors: Ahmed, Sara; Ring, Lena

Assessment of the cost-effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
pp. 491-500(10)
Authors: Dasbach, Erik J; Largeron, Nathalie; Elbasha, Elamin H

Valuing healthcare under Taiwan's national health insurance
pp. 501-508(8)
Authors: Chen, Wen-Yi; Lee, Jwo-Leun; Liang, Yia-Wun; Hung, Chin-Tun; Lin, Yu-Hui

Acknowledgements
pp. 513-513(1)